Entries by admin

Baxano Surgical, Inc. Announces Closing of $10 Million Private Placement of Convertible Debentures

RALEIGH, N.C., April 23, 2014 (GLOBE NEWSWIRE) — Baxano Surgical, Inc. (NASDAQ:BAXS) (“Baxano Surgical” or the “Company”), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, announced today that it has entered into a definitive agreement with entities affiliated with […]

China Is Now World Leader in Graphene and Carbon Nanotube Research

BOSTON, MA – April 23, 2014 – Driven by favorable government policies, funding and world-leading academic research, China has become the global leader in graphene and carbon nanotube (CNT) publication and patenting activity. Commercially, it has attained parity with international counterparts in CNT production, though its graphene suppliers lag global competition, according to Lux Research. China’s domestic graphene […]

Neos Therapeutics Announces $20 Million Loan Facility and Updated Total of $18 Million for its Additional Series C Financing

Dallas/Fort Worth, TX (April 23, 2014) – Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has entered into a $20 million loan facility with Hercules Technology Growth Capital, Inc. (NYSE:HTGC). The […]

Neos Therapeutics Completes $15.5 Million Additional Series C Financing

DALLAS/FORT WORTH, Texas–(BUSINESS WIRE)–Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total of $15.5 million. Investors participating in […]

Ardelyx Licenses NaP2b Phosphate Inhibitor Program for Kidney Disease to Sanofi in Deal Worth up to $198 Million

FREMONT, CA, Feb 24, 2014 (Marketwired via COMTEX) — Ardelyx, Inc. today announced that it has licensed to Sanofi SNY -0.19% (euronext paris:SAN) its novel phosphate transport NaP2b inhibitor program (also known as NaPi2b, Npt2b and SLC34A2). Ardelyx will receive an undisclosed upfront payment from Sanofi. Total development and regulatory milestones could potentially reach up to $198 million. […]

Jobvite Recognized for Outstanding Customer Service in the 2014 Stevie Awards

SAN MATEO, CA –  Jobvite, the comprehensive recruitment platform for the world’s fastest-growing companies, was presented with three customer service-related awards in the 2014 Stevie Awards this past Friday, February 21, in Las Vegas, Nevada. The recipient of the 2014 People’s Choice Stevie® Awards for Favorite Customer Service in the Computer Software (100 or more employees) category, […]

MIT Technology Review Names Arcadia Biosciences to Its 50 Smartest Companies List

DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, has been named to MIT Technology Review’s 2014 50 Smartest Companies list. The list spotlights those companies that over the past year made a difference through their innovations by filling a need or challenging others […]

Odyssey Logistics & Technology Corp. (OL&T) Announces Investment from Goldman, Sachs & Co.

DANBURY, Conn. (Feb. 11, 2014) – Odyssey Logistics & Technology Corporation (“OL&T”), today announced its acceptance of a non-controlling capital investment from Goldman, Sachs & Co. (NYSE: GS). OL&T has indicated that the capital will be used in its ongoing programs of strategic acquisitions and global expansion. “This is an exciting time for Odyssey,” said […]

Auspex Announces Completion Of Initial Public Offering

Auspex Announces Completion Of Initial Public Offering And Exercise In Full Of Underwriters’ Over-Allotment Option   LA JOLLA, Calif., Feb. 10, 2014 /PRNewswire/ — Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the completion of its initial public offering of 8,050,000 shares of its common […]

Velocity Pharmaceutical Development and Tigercat Pharma Inc. Announce Submission of IND Application for VPD-737

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2013 /PRNewswire/ — Velocity Pharmaceutical Development, LLC (“VPD”) and Tigercat Pharma, Inc., (“Tigercat”) announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus. Tigercat licensed worldwide rights to VPD-737 (Serlopitant), an NK-1 receptor antagonist, from […]